课题基金 / 基金详情

CALCITONIN RECEPTORS IN DEVELOPMENT

CALCITONIN RECEPTORS IN DEVELOPMENT
降钙素受体的发育
批准号:
6100314
负责人:
STEVEN GOLDRING
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-01 至 1998-12-31

项目摘要

项目成果

STEVEN GOLDRING的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Calcitonin (CT) was originally identified as a peptide hormone released by parafollicular cells of the thyroid gland in response to hypercalcemic stimuli. In mammals, it was found that CT secretion produces a rapid lowering of extracellular calcium levels by inhibition of bone resorption and stimulation of renal calcium excretion, effects mediated by high affinity receptors located on osteoclasts and certain renal tubular cells. Subsequently, it was shown that CTRs are widely distributed, suggesting that CT may have more complex and diverse functions. CT may also be important in the early differentiation of the vertebrate embryo. The aims of this proposal are to complete the determination of the structure of the murine CTR gene, introduce targeted mutations into the gene by homologous recombination in embryonic stem cells and create transgenic mice that express these mutations in order to define the role of CT and the CTR gene in embryonic development. The zebrafish system will also be used to understand the role of the CTR in early embryonic development. In Specific Aim 1, determination of the structure of the murine CTR gene will be completed and the 5'-regulatory sequences identified. The murine brain CTR cDNA, sequenced in this laboratory, will be used to identify exons in the CTR gene (see Project 4). In Specific Aim 2, restriction fragments prepared from the murine CTR cDNA or the genomic CTR clones will be subcloned into vectors to produce CTR- specific cRNA probes. These will be utilized to localize CTR gene transcripts during various stages of murine development with techniques of in situ hybridization. The pattern of CTR expression determined by in situ hybridization will be correlated with that obtained by autoradiography with radioiodinated CT and immunohistochemistry with CTR antibodies. In Specific Aim 3, homologous recombination in embryonic stem (ES) will be used for targeted disruption of the CTR gene; the ES cells will be used to produce transgenic mice. This will permit direct determination of the consequences of disruption of the CTR gene in murine embryonic development. In Specific Aim 4, the lacZ gene will be placed just downstream from the translation initiation site in the CTR gene by means of homologous recombination of ES cells to produce mutant mice. This approach will permit the determination in vivo of the spatial and temporal expression of the CTR gene and the lineage of cells that express the gene during development. In Specific Aim 5, zebrafish CTR cDNA will be cloned and vectors incorporating these sequences or sequences from the CTR gene will be utilized to examine the consequences of ectopic production or overexpression of CT or the CTR in early embryonic development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ProGel Technology for Better Management of Osteoarthritis Pain
  • 批准号:
    10326409
  • 项目类别:
  • 资助金额:
    $84.04万
  • 财政年份:
    2020
  • 负责人:
    STEVEN GOLDRING
  • 依托单位:
ProGel Technology for Better Management of Osteoarthritis Pain
  • 批准号:
    10013068
  • 项目类别:
  • 资助金额:
    $25.21万
  • 财政年份:
    2020
  • 负责人:
    STEVEN GOLDRING
  • 依托单位:
ProGel Technology for Better Management of Osteoarthritis Pain
  • 批准号:
    10281291
  • 项目类别:
  • 资助金额:
    $84.04万
  • 财政年份:
    2020
  • 负责人:
    STEVEN GOLDRING
  • 依托单位:
CELLULAR RESPONSES TO INORGANIC PARTICULATES
国内基金
海外基金
降钙素基因相关肽(Calcitonin gene-related peptide, CGRP)对穴位敏化的调节及机制研究
  • 批准号:
    81873385
  • 项目类别:
    面上项目
  • 资助金额:
    59.0万元
  • 批准年份:
    2018
  • 负责人:
    乔海法
  • 依托单位: